Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
aggression
algorithm
amnestic syndrome
AMPA receptor antibodies
AMPA receptors
amygdala
anti GQ1b IgG antibody
ataxia
ataxia, cerebellar
autoantibodies
autoimmune basal ganglia encephalitis
autoimmune disease
autonomic dysfunction
basal ganglia, lesion of
basal ganglia, lesion, bilateral
behavior, combative
behavioral disorder
behavioral disorder, acute
carcinoma
carcinoma of lung
CAT scan, chest
catatonia
cerebellum
cerebral cortex
children
chorea
choreoathetosis
collapsin response mediator protein 5 IgG
complications
confusion
contactin associated protein like 2 antibodies
dementia
dementia, reversible
diagnostic criteria
diarrhea
differential diagnosis
DPPX, antibodies, encephalitis
dyskinesia
dyskinesia, facial
dystonia
encephalitis
encephalitis, autoimmune
encephalitis, brainstem
encephalitis, etiology
encephalitis, paraneoplastic
encephalitis, viral
encephalopathy, Hashimoto's
faciobrachial dystonic seizure
false negative
fever
gamma amino butyric acid receptor antibody
gammaglobulin therapy, intravenous
gender
GluD2
glutamic acid decarboxylase, antibody
glycine receptor antibodies
hallucination
hallucination, visual
headache
herpes simplex encephalitis
hippocampus
hippocampus, hyperintense
Hodgkin's disease
Hodgkin's disease, neurologic involvement with
hyperekplexia
hypersomnia
hyponatremia
immunologic disease
immunosuppressive agents
immunotherapy
inappropriate antidiuretic(A.D.H.)hormone
insomnia
insular cortex
intellectual deficit
intellectual deterioration
Jakob-Creutzfeldt disease
leucine rich glioma inactivated 1 antibodies
level of consciousness, decreased
limbic encephalitis
limbic system
malignancy screen
mediastinum, mass of
memory, defect of recent
memory, impairment of
mental status, abnormal
mesial temporal lobe
mimics
misdiagnosis
monoclonal antibodies
Morvan's fibrillary chorea
movement disorder
MRI
MRI, abnormal
MRI, false negative
MRI, FLAIR
MRI, negative
myelitis, transverse, recurrent
myoclonus
negative
neurexin-3 alpha antibodies
neurologic complications of, systemic cancer
neurologic disease, diagnoses of
neuronal cell surface antigen
NMDA antagonists
ophelia syndrome
opsoclonus
opsoclonus-myoclonus syndrome
pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection
personality change
pleocytosis of cerebrospinal fluid
potassium channel antibodies
practice guidelines
precipitating factors
prognosis
psychiatric problems in neurologic disorders
psychosis
Purkinje cell
Purkinje cell surface antibody
recurrent
remote effect of cancer on the nervous system
reversible neurologic disorder
review article
rituximab
screening
seizure
serologic testing
serologic testing, false negative
seronegative
sleep pathology and physiology
steroid
steroid responsive encephalopathy
steroid therapy, CNS treatment and complications with
striatal encephalitis
striatum, lesion of
striatum, lesion of, bilateral
symmetric brain lesions
syphilis, neurologic complications with
temporal lobe
temporal lobe, lesion
temporal lobe, lesion, bilateral
teratoma
teratoma, ovarian
thymoma
treatment of neurologic disorder
tremor
violent behavior
weight loss
white matter disease
white matter disease, subcortical
workup
Showing articles 450 to 500 of 772 << Previous Next >>

Olanzapine Can Worsen Parkinsonism
Neurol 50:1183-1184, Jimenez-Jimenez,F.J.,et al, 1998

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 50:1195-1196, Wolters,E.C.,et al, 1998

A Placebo-ControlledCrossover Study of Rizatriptan in the Treatment of Multiple Migraine Attacks
Neurol 52:773-781, Kramer,M.S.,et al, 1998

Acute Therapy for Cluster Headache with Sumatriptan:Findings of a One-Year Long-Term Study
Neurol 51:980-911, Gobel,H.,et al, 1998

Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998

Ropinirole for the Treatment of Early Parkinson Disease
Arch Neurol 55:1211-1216, Sethi,K.D.,et al, 1998

Multiple Intracerebral Hemorrhages and Vasospasm Following Antimigrainous Drug Abuse
Headache 38:478-480, Nighoghossian,N.,et al, 1998

Autoantibodies to Glutamic Acid Decarboxylase in Three Patients With Cerebellar Ataxia, Late-Onset Insulin-Dependent Diabetes Mellitus, and Polyendocrine Autoimmunity
Neurol 49:1026-1030, Saiz,A.,et al, 1997

Double-Blind Comparison of Pramipexole & Bromocriptine Trtm with Placebo in Advanced Parkinson's Disease
Neurol 49:1060-1065, Guttman,M.,et al, 1997

Characteristics and Determinants of Sumatriptan-Associated Chest Pain
Arch Neurol 54:1387-1392, Ottervanger,J.P.,et al, 1997

Sumatriptan Nasal Spray for Acute Treatment of Migraine, Results of Two Clin Studies
Neurol 49:1225-1230, 11931997., Ryan,R.,et al, 1997

Optimizing the Dose of Zolmitriptan (Zomig, *311C90) for the Acute Treatment of Migraine
Neurol 49:1210-1218, 11931997., Rapoport,A.M.,et al, 1997

Clinical Efficacy and Tolerability of 2. 5Mg Zolmitriptan for the Acute Treatment of Migraine
Neurol 49:1219-1225, Solomon,G.D.,et al, 1997

Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine
Neurol 49:1485-1490, Mathew,T.,et al, 1997

Clinicopath Conf
Rocky Mountain Spotted Fever with Meningoencephalomyelitis, Vasculitis and Focal Myocarditis, Case 3, -17,NEJM 337:1149-1156,1997., 1997

Progression of Ischaemic Stroke and Excitotoxic Aminoacids
Lancet 349:79-83, Castillo,J.,et al, 1997

Continuous Bromocriptine Therapy in Menstrual Migraine
Neurol 48:101-102, Herzog,A.G., 1997

Cabergoline Treatment of Early Parkinson's Disease:First Yr of Trtm Comparison of Cabergoline & Levodopa
Neurol 48:363-368, Rinne,U.K.,et al, 1997

Reversible MRI Findings in a Patient with Hashimoto's Encephalopathy
Neurol 49:246-247, Bohnen,N.I.L.J.,et al, 1997

Sumatriptan for Migraine Attacks in Children:A Randomized Placebo-Controlled Study
Neurol 48:1100-1103, Hamalainen,M.L.,et al, 1997

Safety and Efficacy of Pramipexole in Early Parkinson Disease
Parkinson Study Group, JAMA 278:125-1301997., , 1997

Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997

Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997

Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997

Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997

Chiasmal Herniation as a Complication of Bromocriptine Therapy
J Neuro-Ophthalmol 16:252-257, Taxel,P.,et al, 1996

Restless Legs Syndrome:Clinicoetiologic Correlates
Neurol 47:1435-1441, Ondo,W.&Jankovic,J., 1996

Total Alopecia, Diabetes Mellitus, and Falls
Lancet 348:1420, Mueller-Schoop,J.W., 1996

Use of Sumatriptan in Post-Ictal Migraine Headache
Neurol 47:1104, Jacob,J.,et al, 1996

A Double-Blind Study of Subcut Dihydroergotamine vs Subcut Sumatriptan in Treat of Acute Migraine
Arch Neurol 53:180-184, Winner,P.,et al, 1996

Bromocriptine and Postpartum Cerebral Angiopathy:A Causal Relationship
Neurol 46:1754-1756, Comabella,M.,et al, 1996

A Woman with a Relapsing Psychosis Who Got Better with Prednisone
Lancet 347:1288, Cohen,L.,et al, 1996

Easy Therapeutical Management of Sumatriptan-Induced Daily Headache
Neurol 47:297-298, Gobel,H.,et al, 1996

Diagnosis and Management of Migraine
BMJ 312:1279-1283, Goadsby,P.J.&Olesen,J., 1996

A Comparison of Subcutaneous Sumatriptan and Dihydroergotamine Nasal Spray in the Acute Treatment of Migraine
Neurol 47:361-365, Touchon,J.,et al, 1996

Sumatriptan in Clinical Practice:A 2-year Review of 453 Migraine Patients
Neurol 47:46-51, Visser,W.H.,et al, 1996

Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996

Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996

Rizatriptan vs Sumatriptan in Acute Trmt of Migraine. Dutch/US Rizatriptan Study Group
Arch Neurol 53:1132-1137, Visser,W.H.,et al, 1996

Paraneoplastic Limbic Encephalitis in Hodgkin's Disease
Can J Neurol Sci 23:138-140, Deodhare,S.,et al, 1996

Retroperitoneal Fibrosis in a Patient with Parkinson's Disease Treated with Pergolide
Clin NeuroPharmacol 18:277-279, Jimenez-Jimenez,F.J.,et al, 1995

Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995

The Poisoned Patient with Altered Consciousness, Controversies in the Use of a"Coma Cocktail"
JAMA 274:562-569, Hoffman,R.S.&Goldfrank,L.R., 1995

Electroencephalographic Findings in Hashimoto's Encephalopathy
Neurol 45:977-981, Henchey,R.,et al, 1995

The Use of Sumatriptan in Patients with Monoamine Oxidase Inhibitors
Neurol 45:1039-1040, Diamond,S., 1995

Oral Sumatriptan in Prevent Headache Recurr after Trmt of Migraine with Subcut Sumatriptan
Neurol 45:1505-1509, Rappoport,A.M.,et al, 1995

Oral Sumatriptan for the Acute Treatment of Migraine:Eval of Three Dosage Strengths
Neurol 45:S5-S9, Cutler,N.,et al, 1995

Oral Sumatriptan is Effective & Well Tolerated for the Acute Trmt of Migraine:A Multictr Study
Neurol 45:S10-S14, S31995., Sargent,J.,et al, 1995

Oral Sumatriptan for the Long-Term Treatment of Migraine:Clinical Findings
Neurol 45:S15-S20, Rederich,G.,et al, 1995

Cardiac Arrest Following the Use of Sumatriptan
Neurol 45:1211-1213, Kelly,K.M., 1995



Showing articles 450 to 500 of 772 << Previous Next >>